chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fatigue; mild headache; This is a spontaneous report from a non-contactable consumer, the patient. A 53-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via unspecified route of administration, in left arm on 20Mar2021 at 11:15 AM (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history was reposted as none. Concomitant medication was not reported. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not tested for COVID-19 since having the vaccine. Patient had no allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 22Mar2021 at 13:00, the patient experienced fatigue and headache. The patient did not receive any treatment for the events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome for events fatigue and headache were resolved on an unknown date.   No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Patient cried for non-stop for 24 hours after the dose. No fever over 100. The crying stopped almost 24 hours to the hour from the time the vaccination was administered. Patient had decreased appetite during this time.
patient called 9/30 reporting that patient woke up 9/30 and noticed left arm near injection site was slightly red and itchy. Patient reported arm wasn't really sore anymore and patient denied fever. Patient was informed to take benadryl and monitor swelling to see if condition worsens and to seek medical care if condition does not improve
Arm has rash and hard bump at injection site. This is still persistent after 2 days, it started a few hours after receiving the vaccine and hasn't gone away yet. I only got a little bump after my first dose immediately after, but this is far worse after my second dose. There is a lot of pain in general and it becomes even worse when my arm touches even fabric.
Events: Soar arm, chills, slight fever, aching muscles and joints Treatment: Tylenol Outcome: Resolved in two days
Vaccine administered on 10/14/13. Local redness, swelling, itching, hotness to touch. Mom gave BENADRYL for itching and TYLENOL and ibuprofen for discomfort. Symptoms starting to improve on 10/20/13.
Apparent erythema multiforme recession. Erythematous papular / macules on arms/trunk. Raised irregular plagues on ankles.
nausea and vomiting and diarrhea with stomach cramps for 24 hours
rxn to DTAP erythema 2.5in nodule 5inch in site;mom came in 8/2/99;had marked erythema site;
Pt received Varicella vaccine on 8/2/06 at previous pediatric office. Pt diagnosed with shingles on 2/1/2010. Reporting this to help quantify rates of shingles post vaccine vs. natural disease, not reporting as an adverse event.
8SEP97 rash on face, arms & body;12SEP97 joints ached so much that couldn't walk;joints were edematous too;15SEp better but hands & fingers were stills swollen & stiff;parotid glands were swollen;eyes were red & watery;23SEP97 discomfort
This spontaneous report as received from a 28 year old pregnant female refers to herself. The patient had drug reactions/allergies with penicillin. The patient had no known pertinent medical history. On 17-JAN-2014, the patient was vaccinated with the second dose of MMR II (lot # H015833, expiry date 24-AUG-2014) injection for immigration purposes (dose, strength and route not reported). The patient was vaccinated with her first dose of MMR II (lot#, expiry date, dose, strength and route not reported) in her childhood. No concomitant medication was reported. The patient became pregnant with Last Menstrual Period (LMP) of 24-DEC-2013 (subtract 6 weeks of pregnancy from 04-FEB-2014) and Estimated date of delivery (EDD) of 30-SEP-2014. The patient reported that she had now discovered that she was currently 6 weeks pregnant as of today, 04-FEB-2014 which she confirmed that a positive urine pregnancy test. The patient also stated that 2 weeks after vaccination (on 31-JAN-2014) she developed a red rash that was not itchy on her abdomen. The patient didn't seek medical attention at this time. The patient was treated with EXODERM topical cream. The rash still remained at this time. Additional information is not expected.
Last night, evening around 8pm, rash on torso, front and back, between breast and over whole; Sunday felt tired, took a nap for 3-4 hours; Second shot - soreness in location where vaccine administered on arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Last night, evening around 8pm, rash on torso, front and back, between breast and over whole), VACCINATION SITE PAIN (Second shot - soreness in location where vaccine administered on arm) and FATIGUE (Sunday felt tired, took a nap for 3-4 hours) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 029L20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Allergy to Sulfa drugs).   On 27-Feb-2021 at 1:30 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced VACCINATION SITE PAIN (Second shot - soreness in location where vaccine administered on arm). On an unknown date, the patient experienced RASH (Last night, evening around 8pm, rash on torso, front and back, between breast and over whole) and FATIGUE (Sunday felt tired, took a nap for 3-4 hours). At the time of the report, RASH (Last night, evening around 8pm, rash on torso, front and back, between breast and over whole) had not resolved and VACCINATION SITE PAIN (Second shot - soreness in location where vaccine administered on arm) and FATIGUE (Sunday felt tired, took a nap for 3-4 hours) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Patient fainted after receiving flu vaccine. Placed on floor with legs elevated, ice pack applied to head and neck. 4:35 PM BP= 112/68, P=70, R=20. PEERLA, Pulse strong and regular. 4:45 BP=110/62, P=74, R=20. 5:00 BP=110/64, P=72, R=20. After resting patient felt better after approx 30 mins.
Patient experienced a rash that was fairly itchy that lasted at least 1 week. Patient states did not treat, that rash went away on its own.
This non-serious spontaneous case, initially received on 07-Feb-2018, was reported by healthcare professional (pharmacist), concerning a 27-year-old, pregnant patient. On 05-Feb-2018, the patient was administered with AFLURIA (TIV) (batch number: 15149211A, expiry date: 30-Jun-2018, route of administration: intramuscular, anatomical site: deltoid). Follow-up received from other health professional on 27-Feb-2018: The reporter confirmed that, no information was available regarding LMP (last menstrual period). Added vaccination details (dose: 05. ml, route of administration: intramuscular, anatomical location: deltoid). Narrative was amended accordingly.
CALVES SWOLLEN; HEART RACING; CALVES TENSE; FEELING BAD; HEAVINESS IN CHEST, ESPECIALLY IN HORIZONTAL POSITION; LEGS HURTING; HANDS SHAKING; WORSENING BREATHING PROBLEM; TIREDNESS; ALLERGY; ELEVATED TEMPERATURE; SNEEZING; RUNNING NOSE; STRONG COUGH; This spontaneous report received from a patient concerned a 31 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: pcos (polycystic ovarian syndrome), hashimoto's disease, insulin resistance, non smoker, and non alcoholic, and other pre-existing medical conditions included: The Patient stated that she ate healthy, exercise regularly. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on AUG-2021 for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included levothyroxine sodium for hashimoto's disease, and metformin for insulin resistance. On AUG-2021, the patient experienced running nose. On AUG-2021, the patient experienced strong cough. On AUG-2021, the patient experienced sneezing. On AUG-2021, the patient experienced worsening breathing problem. On AUG-2021, the patient experienced tiredness. On AUG-2021, the patient experienced allergy. On AUG-2021, the patient experienced elevated temperature. Laboratory data included: Body temperature (NR: not provided) elevated. Treatment medications included: paracetamol. On an unspecified date, the patient experienced calves swollen, heart racing, hands shaking, calves tense, feeling bad, heaviness in chest, especially in horizontal position, and legs hurting. Laboratory data (dates unspecified) included: Blood test (NR: not provided) Normal, COVID-19 virus test (NR: not provided) Negative, Chest X-ray (NR: not provided) everything looked normal, and EEG (NR: not provided) Normal. Additional treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from tiredness, elevated temperature, strong cough, legs hurting, calves swollen, heart racing, hands shaking, worsening breathing problem, calves tense, feeling bad, heaviness in chest, especially in horizontal position, and allergy, and the outcome of sneezing and running nose was not reported. This report was non-serious.
Sharp, painful cramp in right rib cage that was provoked by certain movements.  Blood clot?  Resolved within 24 hours.
Local hives, swelling, and redness to injection site of right anterolateral thigh.
no adverse event, but patient lied about age. was actually 12, too young to receive this vaccine
Dr. diagnosed thumb arthritis. Due to my age, I think this is completely coincidental AND NOT RELATED TO THE VACCINATION IN ANY WAY, but I was asked by text if I had sought treatment for any reason, so I am reporting it here.   I am receiving OT for arthritis now.
armpit area and under the arm, patient havea lot of pain and discomfort; armpit area and under the arm, patient havea lot of pain and discomfort; lymph nodes were compromised and patient have swelling in the armpit area and under the arm; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0168) via an unspecified route of administration in the right arm on an 03May2021 at 10:30 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient not had any known allergies to medication, food or any other products. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the right arm on an unknown date (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination.  Since the vaccination, the patient had not been tested for COVID-19. On 25May2021 at 02:00 after receiving the second Pfizer vaccine, the patient experienced lymph nodes were compromised, patient had swelling in the armpit area and under the arm, the patient had a lot of pain and discomfort in that area, it was the side where patient received his vaccinated. The event did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events included cold water compress, ibuprofen and patient took rest. The clinical outcome of the events swelling in the armpit area and under the arm, patient had a lot of pain and discomfort in that area were not recovered at the time of this report.
Headache, Myalgia, chills, injection site pain radiating to neck, fatigue Narrative: Later in the day (following her second dose of the vaccine), the patient reported feeling sleepy. The following day, she reported chills, a  headache, injection site pain, and pain radiating to neck. She denied seeking any treatment.
LUE pounding pain to touch @ 5, red, warm, swollen did not report to infection control nurse until 1-20-10. Vaccination given 1-18-10. RN suggested to see MD immediately.
As with the first shot patient experienced fatigue and weakness for two days following the vaccine.  There was also pain around the site of the injection that lasted for more than two days.
17 year old given two immunizations (COVID and MenQuadfi) in her left arm. After receiving HPV9 vaccine in right arm client went pale, became non-responsive, and lost consciousness. The nurses lowered her to the ground and put her feet on a chair above her heart. She quickly regained consciousness after that. Nurses took her blood pressure once she was sitting up again (98/60) gave her juice, water and a granola bar to eat. She walked out of the public health center under her own power.
erythema and swelling around eyes and lateral neck--slowly resolving --thus far 11 days out
Information has been received from a nurse practitioner's and an office receptionist concerning a 13 year old female patient who was vaccinated "sometime last week" with a dose of GARDASIL (Lot # not provided). Concomitant therapy included influenza virus vaccine (unspecified). Receptionist reported that the patient received a dose of GARDASIL and a dose of influenza virus vaccine (unspecified). Immediately after receiving the GARDASIL the patient passed out and had a shaking seizure which ended quickly. No ill effects since then. Upon internal review, shaking seizure was determined to be another important medical event. Additional information has been requested.
PATIENT WAS GIVEN A SECOND BOOSTER, WHICH IS NOT INDICATED AT THIS TIME.
3 patients administed a dose of Moderna from a vial that had been punctured for more than 12 hours; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (3 patients administed a dose of Moderna from a vial that had been punctured for more than 12 hours) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Apr-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (3 patients administed a dose of Moderna from a vial that had been punctured for more than 12 hours). At the time of the report, EXPIRED PRODUCT ADMINISTERED (3 patients administed a dose of Moderna from a vial that had been punctured for more than 12 hours) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Vail was punctured around 11:50/11:52 AM on 19-Apr-2022 and first booster dose was administered to patient on 20-Apr-2022 around 11:51 AM Treatment information was not provided.   This case was linked to MOD-2022-545341, MOD-2022-546074.
CLIENT RECEIVED VACCINATION AND IMMEDIATLEY REPORTED FEELING HOT, DIZZY, AND HEADACHE.  HE WAS POSTIONED IN A SUPINE POSTION WITH HEAD UP.  VS 6:20 180/120,HR 98, RR 20.  6:35 140/100, AND REPORTED FEELING BETTER.  6:50 BP 130/90 AND ABLE TO SIT UP AND DRINK WATER.  VSS AND ADVISED TO MAKE APPOINTMENT TO F/U WITH A PCP.
Stomach pain; Fever; Nausea; Body ache; Headache; Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), ABDOMINAL PAIN UPPER (Stomach pain), PYREXIA (Fever), NAUSEA (Nausea) and MYALGIA (Body ache) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced DIARRHOEA (Diarrhea) and HEADACHE (Headache). On 25-Feb-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach pain), PYREXIA (Fever), NAUSEA (Nausea) and MYALGIA (Body ache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; LOPERAMIDE HYDROCHLORIDE (IMODIUM) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, DIARRHOEA (Diarrhea), ABDOMINAL PAIN UPPER (Stomach pain), PYREXIA (Fever), NAUSEA (Nausea), MYALGIA (Body ache) and HEADACHE (Headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently 92-year-old female patient. No information was provided regarding medical history, concurrent conditions, or concomitant medications.  On an unknown date in 2015, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose# and route were not specified) for the long-term prevention of shingles and zoster-related conditions. On an unspecified date, the patient experienced shingles. On an unspecified date, the patient was treated by a physician for shingles. The outcome of the event was not reported. The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).
Felt like she had an UTI; Pain; Sore arm, arm is killing her; Red mark at injection site; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (Felt like she had an UTI), PAIN (Pain), PAIN IN EXTREMITY (Sore arm, arm is killing her), VACCINATION SITE ERYTHEMA (Red mark at injection site) and MYALGIA (Body aches) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 19-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URINARY TRACT INFECTION (Felt like she had an UTI), PAIN (Pain), PAIN IN EXTREMITY (Sore arm, arm is killing her), VACCINATION SITE ERYTHEMA (Red mark at injection site) and MYALGIA (Body aches). At the time of the report, URINARY TRACT INFECTION (Felt like she had an UTI), PAIN (Pain), PAIN IN EXTREMITY (Sore arm, arm is killing her), VACCINATION SITE ERYTHEMA (Red mark at injection site) and MYALGIA (Body aches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
patient presented to emergency department on 10/8/21 with cough for 3 days and shortness of breath. patient was recently diagnosed with covid-19  on 10/3/21. patient was diagnosed with pneumonia due to covid-19 patient was admitted to hospital on 10/8/21 patient received remdesivir for 3 days patient was discharge to home on 10/12/21
AFTER PATIENT RECEIVED THE VACCINE, SHE SAID THE NEXT MORNING, SHE WOKE UP WITH AN ARM RASH AND SHE HAD SHORTNESS OF BREATH.   IF IT GETS WORSE, SHE WILL SEEK MEDICAL HELP
Severe lower back spasm with SOB due to pain and flushing of facial cheeks. Pt seen again by PCP then given Dexamethasone 4mg mixed with DEPO-MEDROL 40mg IM (advised it would spike glucose). Patient kept for observation and gave verbal that she was feeling ok after sitting up for 45 mins and had spouse drive her home.
no pain at first then it started; This is a spontaneous report received from a contactable reporter(s) (Other HCP).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN (non-serious), outcome "unknown", described as "no pain at first then it started".  Additional information included: Information of expiry Date of COVID 19 vaccine, other products, patient history and investigation assessment were not provided at the time of report. Reporter stated her husband had received the vaccine and had no pain at first then it started. Reporter declined to complete report at that time.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Case fully vaccinated with Pfizer. Last dose on 2/26/2021. Tested positive for COVID on 9/16/2021. Admitted to Hospital on 9/11/2021. Expired while still hospitalized on 9/27/2021.
pruritic, generalized rash, 6AM following inject the evening a/; tx Celestone, DPH, APAP;
it is really hurting; It hurts to talk because my issue is in my mouth; Uvula is swollen with the sore on it; Uvula is really swollen and it's got a mass of sore on it; Fever; sore throat; This is a spontaneous report from a contactable consumer or other non hcp. A patient of unspecified age and gender received second dose bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: FC3183), via an unspecified route of administration on an unspecified date as a single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Historical vaccine includes patient received first dose bnt162b2 on an unspecified date (Batch/Lot Number: FC3180) as a single dose for covid-19 immunization. On an unspecified date the patient experienced it is really hurting, it hurts to talk because my issue is in my mouth, uvula is swollen with the sore on it, uvula is really swollen and it's got a mass of sore on it, fever and sore throat. Patient was experiencing the side effect of the second dose of Pfizer. Patient had the code that the dose patient had. Patient was experiencing a side effects from the second round of Pfizer. It hurts to talk because patient's issue is in its mouth. So, patient was trying to like cut down on all the talking that patient was doing because it really hurts to talk. Patient was looking to see if it is something, someone that can help me or if there has been any other reaction, a reported reaction like this. Patient was just trying to hurry so patient can find relief. patient can call that number right now. Patient got second round of Pfizer 2 days ago. Yesterday patient experienced a fever and a sore throat in the afternoon. Mind you patient got second late afternoon, very late afternoon two days ago, so yesterday afternoon  started showing side effects fever and a sore throat. The sore throat has stays the same but it turned out that it's not a sore throat, patient looked into its mouth right now, well actually patient looked into its mouth about an hour ago and its uvula was swollen with the sore on it and patient was not feeling like that prior to its injection. Patient was actually feeling really good, really healthy but prior to its second round and then patient called pharmacy where patient received second round of Pfizer and they told patient to call this number. Events were reported as non-serious. The outcome of events was unknown.  Follow-up (20Oct2021): Follow-up attempts completed. No further information expected.
Chills, Sweats, vomiting, diarrhea, dizziness, weakness, spots before my eyes, resulting in admittance to the emergency dept. of the local hospital.